Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

September 30, 2026

Conditions
Acute Kidney Injury Requiring Continuous Renal Replacement Therapy
Interventions
DRUG

Dialysate fluid, Filtration replacement fluid

Dose of continuous hemodialysis and/or hemofiltration

Trial Locations (9)

983-8520

NOT_YET_RECRUITING

Sendai Medical Center, Sendai

569-8686

NOT_YET_RECRUITING

Osaka Medical and Pharmaceutical University Hospital, Takatsuki

910 1193

NOT_YET_RECRUITING

University of Fukui Hospital, Fukui

300 0028

RECRUITING

Tsuchiura Kyodo General Hospital, Ibaraki

565 0871

NOT_YET_RECRUITING

Osaka University Hospital, Osaka

329 0498

NOT_YET_RECRUITING

Jichi Medical University Hospital, Tochigi

105 8471

RECRUITING

Jikei University Hospital, Tokyo

160 0016

RECRUITING

Keio University Hospital, Tokyo

641 8509

NOT_YET_RECRUITING

Wakayama Medical University Hospital, Wakayama

All Listed Sponsors
collaborator

University of Fukui

OTHER

collaborator

Tsuchiura Kyodo General Hospital

OTHER

collaborator

Keio University

OTHER

collaborator

Wakayama Medical University

OTHER

collaborator

Jichi Medical University

OTHER

collaborator

Sendai Medical Center

UNKNOWN

collaborator

Osaka Medical and Pharmaceutical University Hospital

UNKNOWN

lead

Jikei University School of Medicine

OTHER